Tuesday, April 28
7:00 – 4:30 pm
7:30 – 8:15 am
Breakfast with The Rock Stars
8:00 – 5:00 pm
8:15 – 9:430 am
Opening Plenary Session
The Tsunami is Underway & Healthcare will Never be the Same: A Look at Healthcare in the Modern Tech Era
While technological and digital advances are poised to impact every facet of healthcare – personalized diagnostics, precision therapeutics, artificial intelligence, new clinical care models, patient influence, population outcomes and consumer driven care – the rate and pace of this change is staggering and will have differing investment timelines and opportunities. Hear a leading expert paint the “Big Picture" of the transformation that is underway and its future implications.
Presenter: Ralph Snyderman, MD, Chancellor Emeritus, Duke University
9:30 – 9:45 am
9:00 – 12:00 pm
9:45 – 10:30 am
Metabesity: A Healthcare Burden on the Rise
10:30 – 11:15 pm
Dementia: A Tsunami Underway
Phyllis Ferrell, VP, Global Alzheimer’s Disease Platform Team, Eli Lilly and Company
Howard Fillit, Executive Director & CSO, The Alzheimer’s Drug Discovery Foundation
Angus Grant, CEO, Dementia Discovery Fund
11:15 – 12:00 pm
What’s Next in Gene Editing
12:00 – 1:45 pm
Change is Coming: Can we Support it?
How can we optimize our innovation ecosystem, so that it serves the most good for the greatest amount of people? With the developed world dedicating increasingly more resources to new health solutions, questions of access and equitability are relevant to both the mission of better health for all, as well as to the global business opportunities.
2:00 – 4:00 pm
2:00 – 2:45 pm
The Future of Aging: Vitality vs Disease
2:45 – 3:30 pm
Bioelectronic Medicine: Healthcare Innovation from a Wall Socket Near You
Electricity as a therapeutic has been used to re-right heartbeats, to stimulate nerves, neurochemicals and cellular regeneration. Today there is a surge of new medical devices being developed and new bioelectrical treatments for everything from treating a host of CNS diseases to cancer and diabetes. Join our panel of experts as we discuss recent research, the favorable regulatory environment and new business models around the electrifying new wave of potential for bioelectrical therapeutics.
Beth Rogozinsky, CEO, Signal2Health
Brad Schmidt, CEO, Panaxium
3:30 – 4:15 pm
Direct to Consumer Marketing – An Indication of the Future
On these sites, people self-diagnose and select the drug they want, then enter some personal health and credit information. A doctor then assesses their choice, with no in-person consultation. If approved, the medicine arrives in the mail days or weeks later. The sites invert the usual practice of medicine by turning the act of prescribing drugs into a service. Instead of doctors making diagnoses and then suggesting treatments, patients request drugs and physicians serve largely as gatekeepers card information.
4:15 – 5:00 pm
Brain-Mind Interface – A Two-Way Street
5:00 – 5:45 pm
Meet the New Disrupters Who are Changing Healthcare Today
6:00 – 7:30 pm